Pete Wheatstone

Mr. Pete Wheatstone

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2024 in Research Involvement and Engagement
Verified
Journal Article
Open access
PDF file
WCWilliam J. Cragg
William J. Cragg
LBLiam Bishop
Liam Bishop
RGRachael Gilberts
Rachael Gilberts
MGMichael Gregg
Michael Gregg
TLTerry Lowdon
Terry Lowdon
PWPete Wheatstone
Pete Wheatstone
Background: Research study participants can stop taking part early, in various circumstances. Sometimes this experience can be stressful. Providing participants with the information they want or need when they stop could improve participants’ experiences, and may benefit individual studies’ objectives and research in general. A group of public contributors and researchers at the Clinical Trials Research Unit, University of Leeds, aimed to develop a communication template and researcher guidance. This would address how to provide information sensitively around the time when participants stop or significantly reduce their level of participation. Methods: The project lead used scoping review methods to identify relevant prior evidence and derive a list of potential information topics to communicate to participants who stop taking part. The topic list was reviewed by research professionals and public contributors before finalisation. Further public contributors were identified from a range of networks. The contributors formed a ‘development group’, to work on the detail of the planned resources, and a larger ‘review group’ to review the draft output before finalisation. The involvement was planned so that the development group could shape the direction and pace of the work. Results: The literature review identified 413 relevant reports, resulting in 94 information topics. The review suggested that this issue has not been well explored previously. Some evidence suggested early-stopping participants are sometimes excluded from important communications (such as study results) without clear justification. The development group agreed early to focus on guidance with reusable examples rather than a template. We took time to explore different perspectives and made decisions by informal consensus. Review group feedback was broadly positive but highlighted the need to improve resource navigability, leading to its final online form. Conclusions: We co-developed a resource to provide support to research participants who stop taking part. A strength of this work is that several of the public contributors have direct lived experience of stopping research participation. We encourage others to review the resource and consider how they support these participants in their studies. Our work highlights the value of researchers and participants working together, including on complex and ethically challenging topics.

21 January 2025 in Sensors
Verified
Journal Article
Open access
PDF file
RARamesh Arasaradnam
Ramesh Arasaradnam
AKAshwin Krishnamoorthy
Ashwin Krishnamoorthy
MHMark Hull
Mark Hull
PWPete Wheatstone
Pete Wheatstone
FKFrank Kvasnik
Frank Kvasnik
Krishna PersaudKrishna Persaud
Krishna Persaud
The profile of Volatile Organic Compounds (VOCs) may help prioritise at-risk groups for early cancer detection. Urine sampling has been shown to provide good disease accuracy whilst being patient acceptable compared to faecal analysis. Thus, in this study, urine samples were examined using an electronic nose with metal oxide gas sensors and a solid-phase microextraction sampling system. A calibration dataset (derived from a previous study) with CRC-positive patients and healthy controls was used to train a radial basis function neural network. However, a blinded analysis failed to detect CRC accurately, necessitating an enhanced data-processing strategy. This new approach categorised samples by significant bowel diseases, including CRC and high-risk polyps. Retraining the neural network showed an area under the ROC curve of 0.88 for distinguishing CRC versus non-significant bowel disease (without CRC, polyps or inflammation). These findings suggest that, with appropriate training sets, urine VOC analysis could be a rapid, low-cost method for early detection of precancerous colorectal polyps and CRC.

19 November 2026 in Perioperative Medicine
Verified
Journal Article
Open access
ATAmelia Talbot
Amelia Talbot
CFClaire Foster
Claire Foster
SJSusan A. Jebb
Susan A. Jebb
PWPete Wheatstone
Pete Wheatstone
SBSimon Buczacki
Simon Buczacki
DKDimitrios Koutoukidis
Dimitrios Koutoukidis
Background: Healthcare professionals (HCPs) are gatekeepers to recruitment in cancer trials. We aimed to explore HCPs views on recruiting to and delivering a trial of an intensive weight loss programme with dietetic support as prehabilitation before cancer surgery. Methods: This was a qualitative study using semi-structured interviews with dietitians, nurses, and surgeons delivering the trial. Data were analysed descriptively, followed by a framework approach to chart the findings against the RE-AIM framework (reach, effectiveness, adoption, implementation, maintenance) to evaluate the scalability of the intervention. Results: We interviewed six research nurses, four nurse specialists, and two surgeons from eight NHS recruiting hospitals in England and the three dietitians delivering the intervention. HCPs reported approaching most eligible patients but did not approach those thought to be emotionally burdened by their diagnosis (Reach). HCPs also described the programme as a simple way for people to lose weight, potentially improving their postoperative outcomes and allowing them to take control during an uncertain time, though this view compromised equipoise (Effectiveness). While HCPs found it straightforward to deliver the trial and had limited safety concerns, some questioned if the minimum body mass index eligibility of 28 kg/m 2 was too low (Adoption). Dietitians experienced a positive feedback loop when participants adhered to the programme, supporting their perception that the intervention was effective and worthwhile (Implementation). HCPs viewed the programme as filling a gap in prehabilitation but raised concerns about scalability due to limited dietetic workforce capacity (Maintenance). Conclusions: HCPs involved in delivering the programme mostly supported introducing it as prehabilitation before cancer surgery. Scaling the programme may require improvements, particularly to its reach and maintenance. This could include exploring how other trained individuals with appropriate clinical and dietetic oversight could support the delivery of behavioural support. Trial Registration: ISRCTN39207707, prospectively registered 13/03/2023.

20 April 2026 in JMIR Preprints
Verified
Preprint
Open access
KCKerlann Le Calvez
Kerlann Le Calvez
MWMatthew Hardy Williams
Matthew Hardy Williams
JGJonathan J. Gregory
Jonathan J. Gregory
RMRadvile Mauricaite
Radvile Mauricaite
GMGregory Mickiewicz
Gregory Mickiewicz
HWHelen Williams
Helen Williams
BACKGROUND There are more than 3M people in the UK living with a diagnosis of cancer. These are a varied group of people, ranging from those who had curative surgery 20 years ago to those who have exhausted all options and are under palliative care. However, the prevalent population is much larger than the incident population, and is under-researched, and we know very little about their healthcare utilisation or quality of life. In addition, there are open methodological questions about which questionnaires are best to use and how best to ask people for this information. OBJECTIVE To assess the feasibility of implementing, measuring and assessing the impact of timing on completion of questions about data linkage and the performance of different approaches to collecting quality of life and healthcare utilisation data in cancer survivors in a scalable robust manner via a pilot clinical trial. METHODS We designed and implemented an online randomised observational clinical study using an electronic survey platform. We provided trial information and obtained informed consent from all participants online and used randomisation to assess the acceptability of different quality of life tool and to assess the impact of timing on completion of questions about data linkage. We piloted the study in Northwest London and compared our trial population to the underlying patient population from the WSIC dataset. RESULTS 135/345 GP practices in NWL participated, and sent SMS messages to 25044 people, of whom 2518 accessed the survey (9%); in addition, 761 accessed the survey via email and a further 15 participants via social media. 1600 provided informed consent and completed the EQ-5D-5L questionnaire and these formed our analytical cohort. The median age of participants was 68 years; 46% were female, 72% heterosexual. 15% from an ethnic minority. The commonest tumour sites were breast, prostate and colorectal cancer (respectively 35%, 15% and 11%). 67% of participants had been diagnosed more than 5 years ago. 90% described themselves as cured. 46% had accessed healthcare services in the last 12 months. Of those working, 33% had reduced their hours because of their diagnosis. 22% were disabled and 33% reported that the standard QoL questionnaires did not cover their cancer-related symptoms and participant rating of additional QoL questionnaires was broadly similar. 74% agreed to linkage with national cancer data. CONCLUSIONS The implementation, and delivery of an online observational trial are feasible and enable us to recruit a prevalent cancer population, 2/3rds of whom had been diagnosed > 5 years ago. Most participants are happy to allow linkage to national cancer data. We used this pilot phase to refine some of search criteria, and the trial is currently recruiting nationally. CLINICALTRIAL NCT06095024: Investigating Digital Outcomes for Cancer Survivors in the Community. INTERNATIONAL REGISTERED REPORT RR2-https://doi.org/10.1136/bmjopen-2025-104336